FIVOFLU 500MG INJ is a Schedule H drug. FIVOFLU 500MG INJ is composed of: FLUOROURACIL (500.0 MG)
Tag: medicine for colon cancer
FIVOFLU 250MG INJ
FIVOFLU 250MG INJ is a Schedule H drug. FIVOFLU 250MG INJ is composed of: FLUOROURACIL (250.0 MG)
FIVOCIL 500MG INJ
FIVOCIL 500MG INJ is a Schedule H drug. FIVOCIL 500MG INJ is composed of: FLUOROURACIL (500.0 MG)
FIVOCIL 250MG INJ
FIVOCIL 250MG INJ is a Schedule H drug. FIVOCIL 250MG INJ is composed of: FLUOROURACIL (250.0 MG)
EXIT SYP
EXIT SYP is a Schedule H drug. EXIT SYP is composed of: LEVAMISOLE ( ), MEBENDAZOLE ( )
EXIT 100MG/50MG SUSP
EXIT 100MG/50MG SUSP is a Schedule H drug. EXIT 100MG/50MG SUSP is composed of: ALBENDAZOLE (100.0 MG), LEVAMISOLE (50.0 MG)
EXIT 100MG/150MG TAB
EXIT 100MG/150MG TAB is a Schedule H drug. EXIT 100MG/150MG TAB is composed of: LEVAMISOLE (150.0 MG), MEBENDAZOLE (100.0 MG)
ERBITUX 5MG INFUSION
ERBITUX 5MG INFUSION is a Schedule H drug. ERBITUX 5MG INFUSION is composed of: CETUXIMAB (5.0 MG)
ERBITUX 500MG INFUSION
ERBITUX 500MG INFUSION is a Schedule H drug. ERBITUX 500MG INFUSION is composed of: CETUXIMAB (500.0 MG)
ERBITUX 100MG INFUSION
ERBITUX 100MG INFUSION is a Schedule H drug. ERBITUX 100MG INFUSION is composed of: CETUXIMAB (100.0 MG)